High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs

Nucleos(t)ide analogs are used for preventing liver cirrhosis in chronic hepatitis B patients, but the risk factors of hepatocellular carcinoma (HCC) in these patients remain unclear. We designed this retrospective cohort study, the aim is to determine the risk factors for HCC development and its im...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ching-Chung, Bair, Ming-Jong, Liu, Chia-Yuan, Lin, Ze-Yu, Chen, Chih-Jen, Chen, Ming-Jen, Chu, Cheng-Hsin, Wang, Horng-Yuan, Shih, Shou-Chuan, Wang, Tsang-En
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344209/
https://www.ncbi.nlm.nih.gov/pubmed/30608393
http://dx.doi.org/10.1097/MD.0000000000013818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344209/
https://www.ncbi.nlm.nih.gov/pubmed/30608393
http://dx.doi.org/10.1097/MD.0000000000013818

Ejemplares similares